Business Development

Technology Licensing

Technologies needed for GE Healthcare internal programs are in-licensed by a dedicated technology licensing team.

Technology is defined by GE Healthcare as:

  • Pre-IND compounds requiring further pre-clinical development
  • Sponsored Research Agreements
  • Freedom-to-Practice License Agreements
  • Non-product License Option Agreements
  • Other non-product technology licensing deals

Technologies of Interest

  • Ligands targeting specific disease related receptors in:
    • Cardiology
    • Oncology
    • Neurology
    • Internal Medicine (all others)
  • Novel PET and SPECT Agents
  • Novel MRI Agents
  • Novel Ultrasound Agents
  • Novel X-Ray Agents
  • PET Chemistry
  • Novel Imaging Modalities, e.g., Optical

Diseases of Interest

  • CHF
  • Coronary Artery Disease
  • Vulnerable Plaque
  • Stroke
  • Alzheimer's Disease
  • Parkinson's Disease
  • Mood Disorders
  • Cancer
    • Lung
    • CRC
    • Gastric
    • Bladder
    • Prostate
    • Breast
  • Endometriosis
  • COPD
  • Pulmonary Embolism
  • Inflammation
Business Development Links


Contact us

If you are interested in partnering with GE Healthcare please fill in the submission form located on the GE submitting ideas and inventions web site.
 
> Contact Form